about
The use of inhaled corticosteroids in pediatric asthma: updateChiral Alkyl Halides: Underexplored Motifs in MedicineStructure of a 13-fold superhelix (almost) determined from first principles.Immunological characterization of Echinococcus granulosus cyclophilin, an allergen reactive with IgE and IgG4 from patients with cystic echinococcosis.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsivenessEffects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cellsNicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways.New approaches to topical therapy.Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.Understanding cytokines. Part II: Implications for nursing research and practice.Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy?Molecular mechanisms of atopyThe MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.Allergic airway inflammation by nasal inoculation of particulate matter (PM2.5) in NC/Nga mice.Inflammation in allergic asthma: initiating events, immunological response and risk factors.Calcium sensors as new therapeutic targets for asthma and chronic obstructive pulmonary disease.Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.Induction of allergic inflammation by interleukin-18 in experimental animal models.Effect of a 308-nm excimer laser on atopic dermatitis-like skin lesions in NC/Nga mice.Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis.The chemokines secretion and the oxidative stress are targets of low-level laser therapy in allergic lung inflammation.Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice.Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse.Development and Validation of Stability-indicating HPLC Method for Betamethoasone Dipropionate and Related Substances in Topical Formulation.Engineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing.Chemokines and their receptors in the allergic airway inflammatory process.Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma.p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.Nuclear factor-kappaB does not mediate the inhibitory effects of dexamethasone on granulocyte-macrophage colony-stimulating factor expression.Byakangelicol, isolated from Angelica dahurica, inhibits both the activity and induction of cyclooxygenase-2 in human pulmonary epithelial cells.Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone.Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13.The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas.Fusarium solani major allergen peptide IV-1 binds IgE but does not release histamine.Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0.Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients.Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation.
P2860
Q26739763-990E3416-3257-4297-96FF-C1FF4F54E64BQ28066955-4FA8F601-2A07-4FA1-8D25-AB1B2936F0BDQ30152952-6B3ABC56-7878-4212-BEB0-436214AFD133Q31050296-DFC4F63E-73AB-421C-8218-4330C467F5D7Q31134484-3A064D55-3ABA-46C5-894F-C849094F8345Q33695239-B12B21F6-879F-4560-B762-310EF17BB74FQ33726061-A582DB9E-E096-4F19-A03D-DEF20959F46BQ33753476-C8DB06F1-0AE7-4553-AB57-029EC144E6A8Q34106948-266C5A30-3E9E-47B7-AD8D-C5BE278EE29BQ34111660-BE248646-6C0E-4593-A08E-AD4323C334AFQ34171367-55260B54-E751-435E-8B81-15E31FFE279AQ34190513-9552A976-99BD-4D6B-91F1-9AB4EFDCFCF1Q34510796-A71209B9-F2B5-49B4-B45E-B953568A2ADCQ35042474-A9EFFFF6-A88C-4EA5-AD95-B5906ECB3EB6Q35048843-7DD5DF2C-FBDA-47C3-8EB3-7BA0F251EFDBQ35132316-90B57C22-F894-4840-A9A3-E16558B2E18CQ35674994-1BC4B8E8-704C-4338-94FB-5838CCD41754Q35677038-3DE19A6E-CBDA-4874-911B-2D14A82FDB2DQ35746595-EA57E006-EC57-47E6-9E4A-4CD3ADBB656FQ35951814-FF58BBD2-0E9D-4DDB-991E-504DEF12A0DBQ35989102-050606FF-B68D-4ACE-9907-67395A4F8266Q36033294-9E9B2A40-B16C-4DAB-B1FA-9F9D007D73CFQ36138367-1A5F51A4-3C56-43F1-AA22-F376BC004172Q36368668-DCD6C11A-2410-49DC-B10A-B72FDA5E4759Q36399270-0E1DD1F5-398E-4B69-B83E-F2A0E74AE5F4Q36537225-C5709BC4-D2A3-4914-BF44-338A17482E35Q37542225-F8DBF548-6A57-47F3-945C-F6C54E990FF8Q37721300-BAF01D8A-0BBD-4B36-9D9C-C59CCBC9CEEEQ38682652-AA59EB1A-6E62-4045-A7EB-DF8073BB0EEEQ38908783-47BBADBE-E006-4FC2-9C0E-CD4BEABFB668Q40571452-356A17A8-825B-4214-8270-73C4D976F7B8Q40700660-11937484-E244-4F9B-96A4-EE2D57E21D16Q40795700-69DD105B-F916-40E2-AA25-1538857ADD3CQ42001808-E240E3AA-BC23-4408-B4D3-B1CB21E5C6B1Q43616451-B707F361-B8E0-40A1-8A69-46167B5EA4B9Q43650622-319BEF40-A3EB-468C-A0ED-7C317FB7CE9AQ43724347-AB68661B-120D-455A-AF07-7F56FB76F6F3Q44607631-08731413-AC49-4CB8-90DE-1507123E8E64Q44713593-66DEB588-C1A2-4FD7-AFDF-E3E22442029BQ45980761-B94717ED-2980-4794-B2B0-73E4CBB6F232
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapeutic strategies for allergic diseases.
@ast
Therapeutic strategies for allergic diseases.
@en
type
label
Therapeutic strategies for allergic diseases.
@ast
Therapeutic strategies for allergic diseases.
@en
prefLabel
Therapeutic strategies for allergic diseases.
@ast
Therapeutic strategies for allergic diseases.
@en
P2860
P356
P1433
P1476
Therapeutic strategies for allergic diseases.
@en
P2093
P2860
P2888
P356
10.1038/35037026
P407
P433
6760 Suppl
P577
1999-11-01T00:00:00Z
P6179
1029203696